Sinopharm to produce 5 billion doses per year with foreign partners: firm executives

  • China
  • Friday, 14 May 2021

BEIJING (Global Times): China's Sinopharm is expanding the production capacity to five billion doses per year with accelerating overseas cooperation after one of its Covid-19 vaccines was included in the Emergency Using List of the World Health Organisation (WHO), company executives said at a forum on Thursday (May 13) in Shanghai.

Sinopharm has produced more than 400 million doses of Covid-19 vaccines and more than 200 million doses have been supplied at home and abroad, Sinopharm executives said.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

China , Sinopharm , production , increase , covid-19 , vaccine


Next In Aseanplus News

Laos, Brunei elevate ties to strategic partnership
Bangkok mall shooting: Chinese victim and family were hiding in toilet, says niece
N. Korea criticises new US strategy on weapons of mass destruction
Cambodia bars Alternative Nobel Prize winners from travel to awards
Afghanistan dump holders Sri Lanka out of Asian Games cricket
Pahistan star athletes Nadeem injury rules out javelin showdown with Indian world champ Chopra in Hangzhou
Marcos: Philippines looking into ramming incident in South China Sea
Vietnam's economic growth to slow to 4.7% this year: World Bank
China's divers delight, Abdullah sets weightlifting world record on Day 10 of Hangzhou Asian Games
Saudi runner is second competitor to fail dope test at Asiad

Air Pollutant Index

Highest API Readings

    Select State and Location to view the latest API reading

    Source: Department of Environment, Malaysia

    Others Also Read